References
1. Rabe H., Rojas-Anaya H. Inotropes for preterm babies during the transition period after birth: friend or foe? Arch Dis Child Fetal Neonatal Ed. 2017; 102: F547–50.
2. Cox D.J., Groves A.M. Inotropes in preterm infants – evidence for and against. Acta Paediatr. 2012; 101: 17–23.
3. Dempsey E.M., Barrington K.J. Treating hypotension in the preterm infant: when and with what: a critical and systematic review. J Perinatol. 2007; 27: 469–78.
4. Batton B., Li L., Newman N.S., et al. Use of antihypotensive therapies in extremely preterm infants. Pediatrics. 2013; 131: e1865–73.
5. Dempsey E.M., Barrington K.J., Marlow N., et al. Management of hypotension in preterm infants (the hip trial): a randomised controlled trial of hypotension management in extremely low gestational age newborns. Neonatology. 2014; 105: 275–81.
6. Dempsey E.M., Barrington K.J. Diagnostic criteria and therapeutic interventions for the hypotensive very low birth weight infant. J Perinatol. 2006; 26: 677–81.
7. Sehgal A., Osborn D., McNamara P.J. Cardiovascular support in preterm infants: a survey of practices in Australia and New Zealand. J Paediatr Child Health. 2012; 48: 317–23.
8. Batton B., Batton D., Riggs T. Blood pressure during the first 7 days in premature infants born at postmenstrual age 23 to 25 weeks. Am J Perinatol. 2007; 24: 107–15.
9. Laughon M., Bose C., Allred E., et al. Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week. Pediatrics. 2007; 119: 273–80.
10. Stranak Z., Semberova J., Barrington K., et al. International survey on diagnosis and management of hypotension in extremely preterm babies. Eur J Pediatr. 2014; 173: 793–8.
11. Subhedar N.V., Shaw N.J. Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev. 2000; 2: CD001242.
12. Faust K., Hartel C., Preus M., et al. Short-term outcome of very-low-birth-weight infants with arterial hypotension in the first 24 h of life. Arch Dis Child Fetal Neonatal Ed. 2015; 100: F388–92.
13. Batton B., Li L., Newman N.S., et al. Early blood pressure, antihypotensive therapy and outcomes at 18-22 months’ corrected age in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed. 2016; 101: F201–6.
14. Barrington K.J., Dempsey E.M. Cardiovascular support in the preterm: treatments in search of indications. J Pediatr. 2006; 148: 289–91.
15. Dempsey E.M., Al Hazzani F., Barrington K.J. Permissive hypotension in the extremely low birthweight infant with signs of good perfusion. Arch Dis Child Fetal Neonatal Ed. 2009; 94: F241–4.
16. Watterberg K.L., Fernandez E., Walsh M.C., et al. Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants. J Perinatol. 2017; 37: 1220–3.
17. Batton B.J., Li L., Newman N.S., et al. Feasibility study of early blood pressure management in extremely preterm infants. J Pediatr. 2012; 161: 65–9.
18. Steinhorn R.H., Fineman J., Kusic-Pajic A., et al. Bosentan as adjunctive therapy for persistent pulmonary hypertension of the newborn: results of the randomized multicenter placebo-controlled exploratory trial. J Pediatr. 2016; 177: 90–6.
19. Gagliardi L. Treatment of hypotension in preterm infants: pathophysiology versus evidence-based medicine. Acta Paediatr. 2013; 102: 446–8.
20. Padbury J.F. Gasping for air. J Pediatr. 2016; 177: 2–3.
21. Dempsey E.M., Connolly K. Who are the PDCO? Eur J Pediatr. 2014; 173: 233–5.
22. Bravo M.C., Lopez-Ortego P., Sanchez L., et al. Randomized, placebo-controlled trial of dobutamine for low superior vena cava flow in infants. J Pediatr. 2015; 167: 572–8.
23. Durrmeyer X., Marchand-Martin L., Porcher R., et al. Abstention or intervention for isolated hypotension in the first 3 days of life in extremely preterm infants: association with short-term outcomes in the EPIPAGE 2 cohort study. Arch Dis Child Fetal Neonatal Ed. 2017; 102: 490–6.
24. Barrington K.J., Stewart S., Lee S. Differing blood pressure thresholds in preterm infants, effects on frequency of diagnosis of hypotension and intraventricular haemorrhage. Pediatr Res. 2002; 51: 455A.
25. Tarnow-Mordi W., Morris J., Kirby A., et al. Delayed versus immediate cord clamping in preterm infants. N Engl J Med. 2017; 377: 2445–55.
26. Katheria A.C., Lakshminrusimha S., Rabe H., et al. Placental transfusion: a review. J Perinatol. 2017; 37: 105–11.
27. Popat H., Robledo K.P., Kirby A., et al. Associations of measures of systemic blood flow used in a randomized trial of delayed cord clamping in preterm infants. Pediatr Res. 2019; 86: 71–6.
28. Gopel W., Kribs A., Ziegler A., et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011; 378: 1627–34.
29. Azzopardi D., Brocklehurst P., Edwards D., et al. The TOBY study. whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomized controlled trial. BMC Pediatr. 2008; 8: 17.
30. Rich W.D., Auten K.J., Gantz M.G., et al. Antenatal consent in the support trial: challenges, costs, and representative enrollment. Pediatrics. 2010; 126: e215–21.